Resumen de acción THYROCARE
Thyrocare Technologies Limited ofrece servicios de pruebas diagnósticas a pacientes, laboratorios y hospitales de la India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Competidores de Thyrocare Technologies Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹632.40 |
| 52 Week High | ₹722.65 |
| 52 Week Low | ₹433.00 |
| Beta | 0.52 |
| 1 Month Change | 3.53% |
| 3 Month Change | 0.81% |
| 1 Year Change | 37.99% |
| 3 Year Change | -37.86% |
| 5 Year Change | 28.72% |
| Change since IPO | 4.95% |
Noticias y actualizaciones recientes
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Recent updates
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?
Oct 28Insider Buying: The Thyrocare Technologies Limited (NSE:THYROCARE) Chairman Just Bought ₹20m Worth Of Shares
Oct 07The Thyrocare Technologies (NSE:THYROCARE) Share Price Has Gained 51% And Shareholders Are Hoping For More
Sep 29Will Thyrocare Technologies (NSE:THYROCARE) Repeat Its Return Growth Of The Past?
Sep 11Trade Alert: The Chairman Of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Has Just Spent ₹9.6m Buying A Few More Shares
Aug 22Thyrocare Technologies Limited's (NSE:THYROCARE) Price In Tune With Earnings
Aug 17Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Jul 30Investor Optimism Abounds Thyrocare Technologies Limited (NSE:THYROCARE) But Growth Is Lacking
Jul 28Should Weakness in Thyrocare Technologies Limited's (NSE:THYROCARE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 04Rentabilidad de los accionistas
| THYROCARE | IN Healthcare | Mercado IN | |
|---|---|---|---|
| 7D | 1.6% | -3.7% | -1.6% |
| 1Y | 38.0% | 62.3% | 45.0% |
Rentabilidad vs. Industria: THYROCARE obtuvo unos resultados inferiores a los del sector Indian Healthcare , que el año pasado arrojó un rendimiento del 38.6%.
Rentabilidad vs. Mercado: THYROCARE obtuvo unos resultados inferiores a los del mercado Indian, que fue del 45.2% el año pasado.
Volatilidad de los precios
| THYROCARE volatility | |
|---|---|
| THYROCARE Average Weekly Movement | 4.6% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: THYROCARE no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de THYROCARE (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1996 | 1,645 | Rahul Guha | www.thyrocare.com |
Thyrocare Technologies Limited ofrece servicios de pruebas diagnósticas a pacientes, laboratorios y hospitales de la India. Opera en tres segmentos: Servicios de pruebas diagnósticas, Servicios de diagnóstico por imagen y Otros. La empresa realiza diversas pruebas de diagnóstico médico y perfiles de pruebas que se centran en la detección precoz y el tratamiento de trastornos y enfermedades, como tiroides, crecimiento, metabolismo, autoinmunidad, diabetes, anemia, enfermedades cardiovasculares, infertilidad, COVID y diversas enfermedades infecciosas.
Resumen de fundamentos de Thyrocare Technologies Limited
| Estadísticas fundamentales de THYROCARE | |
|---|---|
| Capitalización bursátil | ₹33.62b |
| Beneficios(TTM) | ₹654.50m |
| Ingresos (TTM) | ₹5.54b |
51.4x
Ratio precio-beneficio (PE)6.1x
Ratio precio-ventas (PS)¿Está THYROCARE sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de THYROCARE | |
|---|---|
| Ingresos | ₹5.54b |
| Coste de los ingresos | ₹2.87b |
| Beneficio bruto | ₹2.67b |
| Otros gastos | ₹2.02b |
| Beneficios | ₹654.50m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 12.36 |
| Margen bruto | 48.24% |
| Margen de beneficio neto | 11.82% |
| Ratio deuda/patrimonio | 9.6% |
¿Cómo se ha desempeñado THYROCARE a largo plazo?
Ver rendimiento histórico y comparativa